Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by MSD .
Filed returns
84
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | MSD | Health | Pulmonary Arterial Hypertension (PAH) services (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2026 | MSD | Economic Development and Industry | Private Wires Legislation - energy policy (Legislation) | 2 | On lobbying.ie |
| May–Aug 2026 | MSD | Health | To provide an overview of MSD's operations in Co. Meath and discuss health and industry policy issues (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | National Cancer Strategy & future of cancer care in Ireland (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Engagement on Life Sciences and Innovation Policy (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Cancer Outcomes in Ireland (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2025 | MSD | Health | Health Policy Awareness (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | MSD | Health | Rare disease strategy (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | MSD | Health | Health and industry policy (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | pulmonary arterial hypertension (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | Health and industry policy (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | Advocacy on Pulmonary Arterial Hypertension Policy in Ireland (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2025 | MSD | EU Affairs | Competitiveness in European Union (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | Healthcare Innovation (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2024 | MSD | Health | Health Policy Development for New Programme for Government (Public policy or programme) | 46 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | Meeting to discuss health policy matters with the opposition health spokesperson. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | Meeting to discuss rare disease health policy development in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | pediatric hospitalisations in Ireland due to Varicella in 2023 (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | The improvement of the reimbursement process (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | Access Policy for innovative medicines and rare diseases in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | The importance of predictability in IP rights in the EU Pharmaceutical Legislation revision (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Early detection and treatment of cancer (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Positioning Ireland in the Global Biopharmaceutical Industry (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | National Immunisation programme (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | To highlight problems in Ireland faced by patients with TNBC and policy areas that need focus. (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Access to innovative cancer medicines (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Early detection and treatment of cancer (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Health | Early detection and treatment of cancer (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Economic Development and Industry | Positioning Ireland in the Global Biopharmaceutical Industry (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Health | Immunisation Policies (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Health | Early detection and treatment of cancer (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Health | Reimbursement of innovative oncology medicines and establishment of a National Medicines Agency (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Health | Launch of research report on socio-economic inequalities in cancer (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2022 | MSD | Health | Access to Medicines (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2022 | MSD | Economic Development and Industry | Positioning Ireland in the Global Biopharmaceutical Industry (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2022 | MSD | Health | Oncology Policy (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2022 | MSD | Health | Immunisation Policies (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Policy Priorities in a post-pandemic COVID-19 era (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Immunisation Policies (Public policy or programme) | 26 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Oncology Policy (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Cancer Care in a post-pandemic COVID-19 era (Public policy or programme) | 15 | On lobbying.ie |
| May–Aug 2021 | MSD | Health | Cancer Care in a post-pandemic COVID-19 era (Public policy or programme) | 18 | On lobbying.ie |
| May–Aug 2021 | MSD | Health | Immunisation Policies (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | MSD | Health | Policy Priorities in a post-pandemic COVID-19 era (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2021 | MSD | Health | Oncology Policy (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2021 | MSD | Health | Immunisation Policies (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Policy Priorities in a post-pandemic COVID-19 era (Public policy or programme) | 26 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 34 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Economic Development and Industry | Positioning Ireland in the Biopharmaceutical Industry (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Immunisation Policies (Public policy or programme) | 5 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 74 | 88.1% | |
| Economic Development and Industry | 7 | 8.3% | |
| Communications | 1 | 1.2% | |
| EU Affairs | 1 | 1.2% | |
| Foreign Affairs | 1 | 1.2% |